ZB
WST icon

Zions Bancorporation’s West Pharmaceutical WST Stock Holding History

Zions Bancorporation’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$7.53K Buy
23
+1
+5% +$315 ﹤0.01% 660
2024
Q3 		$6.6K Sell
22
-4
-15% -$1.23K ﹤0.01% 674
2024
Q2 		$8.56K Buy
26
+3
+13% +$1.06K ﹤0.01% 692
2024
Q1 		$9.1K Sell
23
-4
-15% -$1.48K ﹤0.01% 690
2023
Q4 		$9.51K Buy
27
+1
+4% +$354 ﹤0.01% 666
2023
Q3 		$9.76K Hold
26
– – ﹤0.01% 637
2023
Q2 		$9.94K Sell
26
-3
-10% -$1.07K ﹤0.01% 638
2023
Q1 		$10K Buy
29
+7
+32% +$2.04K ﹤0.01% 643
2022
Q4 		$5.18K Sell
22
-36
-62% -$8.53K ﹤0.01% 848
2022
Q3 		$14K Buy
58
+35
+152% +$10.7K ﹤0.01% 614
2022
Q2 		$7K Buy
23
+13
+130% +$4.23K ﹤0.01% 807
2022
Q1 		$4K Buy
10
+1
+11% +$391 ﹤0.01% 1006
2021
Q4 		$4K Buy
9
+5
+125% +$2.15K ﹤0.01% 882
2021
Q3 		$2K Hold
4
– – ﹤0.01% 953
2021
Q2 		$1K Hold
4
– – ﹤0.01% 965
2021
Q1 		$1K Hold
4
– – ﹤0.01% 937
2020
Q4 		$1K Sell
4
-2,133
-100% -$599K ﹤0.01% 923
2020
Q3 		$587K Sell
2,137
-336
-14% -$88.9K 0.08% 99
2020
Q2 		$562K Buy
2,473
+207
+9% +$40.7K 0.08% 99
2020
Q1 		$345K Sell
2,266
-506
-18% -$77.9K 0.06% 118
2019
Q4 		$417K Sell
2,772
-2,481
-47% -$361K 0.06% 123
2019
Q3 		$745K Buy
5,253
+11
+0.2% +$1.51K 0.11% 80
2019
Q2 		$656K Buy
5,242
+155
+3% +$18.3K 0.1% 85
2019
Q1 		$561K Buy
+5,087
New +$529K 0.09% 97
2017
Q4 		– Sell
-14,622
Closed -$1.41M – 980
2017
Q3 		$1.41M Buy
14,622
+2,968
+25% +$269K 0.2% 68
2017
Q2 		$1.1M Buy
+11,654
New +$1.07M 0.19% 67

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Zions Bancorporation's WST Position: Q4 2024 in Review

Zions Bancorporation increased its West Pharmaceutical (WST) stake by 4.5% in Q4 2024, buying an estimated $315 and bringing the position to 23 shares worth $7.53K. The position accounts for ﹤0.01% of the portfolio, ranked #660.

Zions Bancorporation first reported a position in WST in Q2 2017 and has held it in 26 quarters since. The position peaked at $1.41M in Q3 2017. 748 funds tracked by Wall St. Rank hold WST as of Q4 2024.

  • Zions Bancorporation held 23 shares of West Pharmaceutical worth $7.53K as of Q4 2024.
  • Zions Bancorporation bought 1 West Pharmaceutical share in Q4 2024, an estimated $315.
  • West Pharmaceutical made up ﹤0.01% of Zions Bancorporation's portfolio in Q4 2024, its #660 holding.
  • Zions Bancorporation first reported a position in West Pharmaceutical in Q2 2017 and has held it in 26 quarters since.
  • Zions Bancorporation's West Pharmaceutical position peaked at $1.41M in Q3 2017.
  • 748 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2024.

Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.